Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho
Andrew Bryan, Gregory Pepper, Mark H. Wener, Susan L. Fink, Chihiro Morishima, Anu Chaudhary, Keith R. Jerome, View ORCID ProfilePatrick C. Mathias, Alexander L. Greninger
doi: https://doi.org/10.1101/2020.04.27.20082362
Andrew Bryan
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
Gregory Pepper
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
Mark H. Wener
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
2Department of Medicine, University of Washington School of Medicine, Seattle, WA
Susan L. Fink
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
Chihiro Morishima
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
Anu Chaudhary
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
Keith R. Jerome
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
3Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Patrick C. Mathias
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
4Department of Biomedical Informatics and Medical Education, University of Washington School of Medicine, Seattle, WA
Alexander L. Greninger
1Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA
3Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Data Availability
Anonymized data is available upon reasonable request.
Posted May 02, 2020.
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho
Andrew Bryan, Gregory Pepper, Mark H. Wener, Susan L. Fink, Chihiro Morishima, Anu Chaudhary, Keith R. Jerome, Patrick C. Mathias, Alexander L. Greninger
medRxiv 2020.04.27.20082362; doi: https://doi.org/10.1101/2020.04.27.20082362
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho
Andrew Bryan, Gregory Pepper, Mark H. Wener, Susan L. Fink, Chihiro Morishima, Anu Chaudhary, Keith R. Jerome, Patrick C. Mathias, Alexander L. Greninger
medRxiv 2020.04.27.20082362; doi: https://doi.org/10.1101/2020.04.27.20082362
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)